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Abstract There are now nearly 300 single-gene inborn errors
of immunity underlying phenotypes as diverse as infection,
malignancy, allergy, auto-immunity, and auto-inflammation.
For each of these five categories, a growing variety of
phenotypes are ascribed to Primary Immunodeficiency
Diseases (PID), making PIDs a rapidly expanding field of
medicine. The International Union of Immunological Socie-
ties (IUIS) PID expert committee (EC) has published every
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other year a classification of these disorders into tables, de-
fined by shared pathogenesis and/or clinical consequences. In
2013, the IUIS committee also proposed a more user-friendly,
phenotypic classification, based on the selection of key phe-
notypes at the bedside. We herein propose the revised figures,
based on the accompanying 2015 IUIS PID EC classification.
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AD Autosomal dominant inheritance
ADA Adenosine deaminase
Adp Adenopathy
ALPS Autoimmune lymphoproliferative syndrome
AML Acute myeloid leukemia
Anti PPS Anti- pneumococcus antibody
AR Autosomal recessive inheritance
BCG Bacilli Calmette-Guerin
BL B lymphocyte
CAMPS CARD14 mediated psoriasis
CANDLE Chronic atypical neutrophilic dermatosis with
lipodystrophy and elevated temperature
syndrome
CAPS Cryopyrin-associated periodic syndromes
CBC Complete blood count
CD Cluster of differentiation
CDG-IIb Congenital disorder of glycosylation, type IIb
CGD Chronic granulomatous disease
CID Combined immunodeficiency
CINCA Chronic infantile neurologic cutaneous and ar-
ticular syndrome
CMC Chronic mucocutaneous candidiasis
CMF Flow cytometry available
CMV Cytomegalovirus
CMML Chronic myelomonocytic leukemia








DITRA Deficiency of interleukin 36 receptor antagonist
EBV Epstein-Barr virus
EDA Anhidrotic ectodermal dysplasia
EDA-ID Anhidrotic ectodermal dysplasia with
immunodeficiency
EO Eosinophils
FA Frequency of attacks
FCAS Familial cold autoinflammatory syndrome
FILS Facial dysmorphism, immunodeficiency, livedo,
and short stature
FISH Fluorescence in situ hybridization
GI Gastrointestinal
GOF Gain-of-function
HHV8 Human herpes virus type 8
Hib Haemophilus influenzae serotype b
HIDS Hyper IgD syndrome
HIES Hyper IgE syndrome
HIGM Hyper Ig M syndrome
HLA Human leukocyte antigen
HLH Hemophagocytic lymphohistiocytosis
HPV Human papilloma virus
HSM Hepatosplenomegaly
HSV Herpes simplex virus
HUS Hemolytic uremic syndrome
Hx Medical history




IUGR Intrauterine growth retard
LAD Leukocyte adhesion deficiency
LOF Loss-of-function
MC Molluscum contagiosum
MKD Mevalonate kinase deficiency
MSMD Mendelian susceptibility to mycobacterial
disease
MWS Muckle-wells syndrome
N Normal, not low
NK Natural killer
NKT Natural killer T cell
NN Neonatal
NOMID Neonatal onset multisystem inflammatory
disease
NP Neutropenia
PAPA Pyogenic sterile arthritis, pyoderma
gangrenosum, acne syndrome
PMN Neutrophils
SCID Severe combined immuno deficiency
Sd Syndrome
SLE Systemic lupus erythematosus
SPM Splenomegaly
Staph Staphylococcus sp.





TNF Tumor necrosis factor
TRAPS TNF receptor-associated periodic syndrome
VZV Varicella zoster virus
WBC White blood cells
XL X-linked
Introduction
Human Primary Immunodeficiency Diseases (PID) comprise
at least 300 genetically-defined single-gene inborn errors of
immunity [1]. Long considered as rare diseases, recent studies
tend to show that they are more common than generally
thought, if only by their rapidly increasing number [2]. They
may be even more common, if we consider the emerging
monogenic determinants leading to common infectious dis-
eases, such as severe influenza [3]; autoimmune diseases, such
as systemic lupus erythematosus [4], and auto-inflammatory
diseases, such as Crohn’s disease [5]. The International Union
of Immunological Societies (IUIS) PID expert committee has
Fig. 1 Immunodeficiencies affecting cellular and humoral immunity.
ADA Adenosine Deaminase, Adp adenopathy, AR Autosomal Recessive
inheritance, CBC Complete Blood Count, CD Cluster of Differentiation,
CID Combined Immunodeficiency, EBV Epstein-Barr Virus, EO
Eosinophils, HHV8 Human Herpes virus type 8, HIGM Hyper IgM
syndrome, HLA Human Leukocyte Antigen, HSM Hepatosplenomegaly,
HPV Human papilloma virus, IBD Inflammatory bowel disease, Ig
Immunoglobulin, MCMolluscum contagiosum, N Normal, not low, NK
Natural Killer, NN Neonatal, NP Neutropenia, SCID Severe Combined
ImmunoDeficiency, Staph Staphylococcus sp., TCR T-Cell Receptor,
XL X-Linked
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Fig. 2 CID with associated or syndromic features. These syndromes are
generally associated with T-cell immunodeficiency. αFP alpha-
fetoprotein, AD Autosomal Dominant inheritance, AR Autosomal
Recessive inheritance, CMF Flow cytometry available, EDA Anhidrotic
ectodermal dysplasia, EDA-ID Anhidrotic Ectodermal Dysplasia with
Immunodeficiency, FILS Facial dysmorphism, immunodeficiency,
livedo, and short stature, FISH Fluorescence in situ Hybridization, HSM
Hepatosplenomegaly, HSV Herpes simplex virus, Ig Immunoglobulin,
VZV Varicella Zoster virus, WAS Wiskott-Aldrich syndrome, XL
X-Linked inheritance
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Fig. 3 Predominantly Antibody deficiencies. Ab Antibody, Adp
adenopathy, Anti PPS Anti- pneumococcus Antibody, AR Autosomal
Recessive inheritance, CD Cluster of Differentiation, CDG-IIb
Congenital disorder of glycosylation, type IIb, CMV Cytomegalovirus,
CT Computed Tomography, EBV Epstein-Barr Virus, Dip Diphtheria, GI
Gastrointestinal, Hib Haemophilus influenzae serotype b, Hx medical
history, Ig Immunoglobulin, SPM Splenomegaly, subcl subclass, Tet
Tetanus, XL X-Linked inheritance
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Fig. 4 Diseases of Immune Dysregulation. AD Autosomal Dominant
inheritance, ALPS Autoimmune lymphoproliferative syndrome, AR
Autosomal Recessive inheritance, CD Cluster of Differentiation, CMF
Flow cytometry available, CSF Cerebrospinal fluid, CTL Cytotoxic T-
Lymphocyte, EBV Epstein-Barr Virus, GOF Gain-of-function, HLH
Hemophagocytic lymphohistiocytosis, HSM Hepatosplenomegaly, IBD
Inflammatory bowel disease, IFNγ Interferon gamma, Ig
Immunoglobulin, IL interleukin, Inflam Inflammation,NKNatural Killer,
NKT Natural Killer T cell, T T lymphocyte, XL X-Linked inheritance
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Fig. 5 Congenital defects of phagocyte number, function, or both. For
DHR assay, the results can distinct XL-CGD from AR-CGD, and
gp40phox defect from others AR forms. AD Autosomal Dominant
inheritance, AML Acute Myeloid Leukemia, AR Autosomal Recessive
inheritance, BCG Bacilli Calmette-Guérin, CBC Complete Blood Count,
CD Cluster of Differentiation, CGD Chronic Granulomatous Disease,
CMML Chronic MyeloMonocytic Leukemia, DHR DiHydroRhodamine,
IUGR Intrauterine growth retard, LAD Leukocyte Adhesion Deficiency,
NP Neutropenia, PNN Neutrophils, SCN Severe congenital neutropenia,
WBCWhite Blood Cells, XL X-Linked inheritance
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Fig. 6 Defects in Intrinsec and Innate Immunity. AD Autosomal
Dominant inheritance, AR Autosomal Recessive inheritance, BCG
Bacilli Calmette-Guérin, BL B lymphocyte, CMC Chronic
mucocutaneous candidiasis, HSV Herpes simplex virus, IFNγ Interferon
gamma, Ig Immunoglobulin, IL interleukin, LOF Loss-of-function,
MSMD Mendelian Susceptibility to Mycobacterial Disease, PMN
Neutrophils, XL X-Linked inheritance
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Fig. 7 Autoinflammatory Disorders. AD Autosomal Dominant
inheritance, AR Autosomal Recessive inheritance, CAMPS CARD14
mediated psoriasis, CANDLE Chronic atypical neutrophilic dermatosis
with lipodystrophy and elevated temperature syndrome, CAPS
Cryopyrin-Associated Periodic syndromes, CINCA Chronic Infantile
Neurologic Cutaneous and Articular syndrome, DA Duration of
Attacks, DITRA deficiency of interleukin 36 Receptor antagonist, FA
Frequency of Attacks, HIDS Hyper IgD syndrome, Ig Immunoglobulin,
IL interleukin,MKDMevalonate Kinase deficiency,MWSMuckle-Wells
syndrome, NOMID Neonatal Onset Multisystem Inflammatory
Disease, PAPA Pyogenic sterile Arthritis, Pyoderma gangrenosum, Acne
syndrome, SPM Splenomegaly, TNF Tumor Necrosis Factor, TRAPS
TNF Receptor-Associated Periodic Syndrome
J Clin Immunol (2015) 35:727–738 735
Fig. 8 Complement deficiencies. AD Autosomal Dominant inheritance, GOF Gain-of-function, LOF Loss-of-function, LAD Leukocyte Adhesion
Deficiency, SLE Systemic Lupus Erythematosus
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IFNγ Interferon gamma, IL
Interleukin, MSMDMendelian
Susceptibility to Mycobacteria
Disease, VZV Varicella Zoster
virus
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proposed a PID classification [1], which facilitates clinical
research and comparative studies world-wide; it is updated
every other year to include new disorders or disease-causing
genes. This classification is organized in tables, each of which
groups PIDs that share a given pathogenesis. As this classifi-
cation may be cumbersome for use by the clinician at the
bedside, the IUIS PID expert committee recently proposed a
phenotypic complement to its classification [6]. As the num-
ber of PIDs is quickly increasing, and at an even faster pace
since the advent of next-generation sequencing, the phenotyp-
ic classification from 2013 became outdated and requires re-
vision at the same pace as the classical IUIS classification. Our
original phenotypic classification proved successful, which
placed it in the 96th percentile for citation rank in Springer
journals [7]. Given the success of our user-friendly classifica-
tion of PIDs, providing a tree-based decision-making process
based on the observation of clinical and biological pheno-
types, we present here an update of these figures, based on
the accompanying 2015 PID classification.
Methodology
We included all diseases included in the 2015 update of the
IUIS PID classification [1], keeping the nine major categories
unchanged. In addition, we considered other articles propos-
ing a PID classification published recently [8, 9]. An algo-
rithm was assigned to each of the nine main groups of the
classification and the same color was used for each group of
similar conditions. Disease names are presented in red and
genes in bold. In addition, we classed diseases or genes from
most common to less common, at the best of our knowledge
[10, 11]. These algorithms were first established by a small
committee; then validated by one or two experts for each
figure.
Results
An update of our classification, validated by the IUIS PID
expert committee, is presented in Figs. 1, 2, 3, 4, 5, 6, 7, 8
and 9.
Discussion
Since our 2013 study, 70 new diseases have been included in
the 2015 classification. Four disorders have been removed, as
the reports concerning associated immunodeficiency or genet-
ic base were not confirmed. We also eliminated duplication of
a disease in more than one figure and profoundly revised some
figures, following the 2015 IUIS classification.
Conclusion
The IUIS PID expert committee developed this phenotypic
classification in order to help clinicians at the bedside to diag-
nose PIDs but also to promote collaboration with national and
international research centers. Needless to say, the expert com-
mittee encourages the development of other types of PID clas-
sification. Indeed, given the success encountered by the two
current IUIS classifications, others classifications are likely to
be useful and complementary.
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